Seller record · Telehealth service

Coivas

By Paul Harris, Standards EditorRecorded September 2026 · Standard v1.1 · How checks are performed

Fails 3 of 8 criteria. S3, pharmacy identification: The site names no filling pharmacy. Its pharmacy answer says only that Coivas partners with state-licensed 503A compounding pharmacies and 503B outsourcing facilities. 2 more criteria also fail; see the table below.

At a glance

CoivasTelehealth service

5/8criteria passed

Price: Semaglutide $119 a month introductory, then $149
Sells: compounded semaglutide, compounded tirzepatide, sermorelin, and 3 more
FDA letters: None on file

Visit Coivas See all eight dispositions

Telehealth service. Passes 5 of 8 criteria. Recorded against Standard v1.1.

A telehealth service selling compounded semaglutide and tirzepatide, sermorelin, NAD+ injections and nasal spray, with introductory prices that rise after the first billing cycle. It names its clinical provider group but no pharmacy, and prints only New York, NY as an address.

Operating entity WellVi LLC

Dispositions

Code	Criterion	Disposition	Where it appears
S1	Prescriber requirement	PASS	Coivas' website
S2	Prescription gating	PASS	Coivas' GLP page on its intake site; Coivas' website
S3	Pharmacy identification	FAIL	Coivas' website; Coivas' terms
S4	Compounding disclosure	PASS	Coivas' website; Coivas' challenge page
S5	Analytical documentation	FAIL	Coivas' sermorelin product page; Coivas' NAD+ program product page
S6	Business address	FAIL	Coivas' terms; Coivas' privacy page; Coivas' shipping policy
S7	Price disclosure	PASS	Coivas' weight loss product page; Coivas' challenge page; Coivas' sermorelin product page; Coivas' NAD+ program product page
S8	Enforcement status	PASS	FDA warning-letter index

Evidence, criterion by criterion

The evidence behind each disposition in the table above, where it appears, and its date.

S1PASSA licensed provider reviews each intake and performs a clinical evaluation, and the site names its clinical provider as Arora Health & Aesthetics, LLC of 300 Lenora Street, Seattle, WA 98121.Source: Coivas' website.

S2PASSThe start button opens an assessment questionnaire, and the site states that a provider evaluation precedes any prescription and that the price is approved before any charge.Source: Coivas' GLP page on its intake site; Coivas' website.

S3FAILThe site names no filling pharmacy. Its pharmacy answer says only that Coivas partners with state-licensed 503A compounding pharmacies and 503B outsourcing facilities.Source: Coivas' website; Coivas' terms.

S4PASSThe FDA does not review or approve compounded medications for safety or effectiveness, printed in the footer of every page, and each GLP-1 plan is labeled compounded.Source: Coivas' website; Coivas' challenge page.

S5FAILNo certificate of analysis or lot document is published. The product answers state that all formulations undergo third-party testing for potency, sterility and purity, with no document behind the claim.Source: Coivas' sermorelin product page; Coivas' NAD+ program product page.

S6FAILNo street address is printed. The terms, the privacy policy and the shipping and return policies give only New York, NY beside the company name.Source: Coivas' terms; Coivas' privacy page; Coivas' shipping policy.

S7PASSCompounded semaglutide at $119 a month introductory for new GLP-1 users, billed $357 for the first 3 months, then $149 a month. Compounded tirzepatide at $199 a month introductory, then $229. Sermorelin at $119 a month for the first 3 months, then $199, and the NAD+ injection at $99 for the first month on a quarterly plan, then $149.Source: Coivas' weight loss product page; Coivas' challenge page; Coivas' sermorelin product page; Coivas' NAD+ program product page.

S8PASSNo FDA warning letter names Coivas, Coivas Health or WellVi LLC, and no action has halted the business.Source: FDA warning-letter index.

Products shown on the seller's own pages at the recorded date: compounded semaglutide, compounded tirzepatide, sermorelin, NAD+ injection and nasal spray, glutathione, estradiol and progesterone.

Other sellers of the same products

Who sells semaglutide Who sells tirzepatide Who sells sermorelin Who sells NAD+Who sells glutathione

Unpaid link. Coivas does not pay the site, and nothing is earned when it is used. Funding.

Visit Coivas

Dispositions recorded against Standard v1.1. Method and null semantics: how checks are performed. This record is not a review and contains no medical advice.